KR860005814A - 1,6-나프티리딘-2(1h)-온 및 그의 제조방법 - Google Patents

1,6-나프티리딘-2(1h)-온 및 그의 제조방법

Info

Publication number
KR860005814A
KR860005814A KR1019850010151A KR850010151A KR860005814A KR 860005814 A KR860005814 A KR 860005814A KR 1019850010151 A KR1019850010151 A KR 1019850010151A KR 850010151 A KR850010151 A KR 850010151A KR 860005814 A KR860005814 A KR 860005814A
Authority
KR
South Korea
Prior art keywords
naphthyridin
preparation
Prior art date
Application number
KR1019850010151A
Other languages
English (en)
Other versions
KR900004213B1 (ko
Inventor
요어 레셔어 죠오지
싱 발데브
Original Assignee
스터어링 드럭그 인코포레이팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스터어링 드럭그 인코포레이팃드 filed Critical 스터어링 드럭그 인코포레이팃드
Publication of KR860005814A publication Critical patent/KR860005814A/ko
Application granted granted Critical
Publication of KR900004213B1 publication Critical patent/KR900004213B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019850010151A 1985-01-14 1985-12-31 1,6-나프티리딘-2(1h)-온 및 그의 제조방법 KR900004213B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US691802 1985-01-14
US06/691,802 US4567186A (en) 1985-01-14 1985-01-14 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor

Publications (2)

Publication Number Publication Date
KR860005814A true KR860005814A (ko) 1986-08-13
KR900004213B1 KR900004213B1 (ko) 1990-06-18

Family

ID=24778039

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850010151A KR900004213B1 (ko) 1985-01-14 1985-12-31 1,6-나프티리딘-2(1h)-온 및 그의 제조방법

Country Status (8)

Country Link
US (1) US4567186A (ko)
EP (1) EP0191298A3 (ko)
JP (1) JPS61210086A (ko)
KR (1) KR900004213B1 (ko)
AU (1) AU585565B2 (ko)
DK (1) DK13786A (ko)
GR (1) GR860075B (ko)
NZ (1) NZ214788A (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2686612A (en) * 1950-06-13 1954-08-17 Curlee Machinery Company Inc Dispensing machine
US4853395A (en) * 1983-04-29 1989-08-01 Merrell Dow Pharmaceuticals Inc. Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones
ZA9610741B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA985870B (en) * 1997-07-15 1999-01-27 Dainippon Pharmaceutical Co 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
JP2006517976A (ja) * 2003-02-14 2006-08-03 スミスクライン・ビーチャム・コーポレイション 新規化合物
US10815224B2 (en) * 2016-07-14 2020-10-27 Bristol-Myers Squibb Company Monocyclic heteroaryl substituted compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412077A (en) * 1982-03-15 1983-10-25 Sterling Drug Inc. Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
US4415580A (en) * 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4532247A (en) * 1983-08-08 1985-07-30 Sterling Drug Inc. 5-(Hydroxyalkyl or alkanoyloxymethyl)-1,6-naphthyridin-2(1H)-one and cardiotonic use thereof
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US4560691A (en) * 1984-07-13 1985-12-24 Sterling Drug Inc. 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation
NZ214837A (en) * 1985-01-28 1988-10-28 Sterling Drug Inc 5-substituted 1,6 naphthyridin-2(1h)-ones

Also Published As

Publication number Publication date
DK13786D0 (da) 1986-01-13
EP0191298A2 (en) 1986-08-20
DK13786A (da) 1986-07-15
KR900004213B1 (ko) 1990-06-18
EP0191298A3 (en) 1986-12-03
NZ214788A (en) 1988-09-29
JPS61210086A (ja) 1986-09-18
GR860075B (en) 1986-05-14
AU5187386A (en) 1986-07-17
US4567186A (en) 1986-01-28
AU585565B2 (en) 1989-06-22

Similar Documents

Publication Publication Date Title
NZ220853A (en) Imidazopyridine, intermediates and preparation
NL300014I1 (nl) Chinolinederivaten en bereidingsprocessen hiervoor.
DE3675824D1 (de) Antianaphylaktische und antibronchospastische n-benzhydrylcycloalkylalkananilide.
FI870439A0 (fi) Apparat foer framstaellning av kapslar med flera kamrar.
TR22532A (tr) Piridazinon tuerevleri,bunlarin hazirlanmasi ve ensektisid,akarisid nematisid fungisid bilesikleri
DE3571437D1 (de) Pyrazolopyridine derivatives
KR860005810A (ko) 4h-1-벤조피란-4-온 및 그 제조방법
KR860005814A (ko) 1,6-나프티리딘-2(1h)-온 및 그의 제조방법
DE3664774D1 (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
IL81042A0 (en) Pyridine derivatives and n-oxides thereof,processes for their preparation and the use thereof as intermediates
MA20660A1 (fr) Derives de nitrofuranne, leur preparation et leur application
DK615086D0 (da) 5,6-dialkoxy-4-imino-2(1h)quinazolinderivater
FR2568879B1 (fr) Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique
IT1187681B (it) Metodo per la preparazione di 3,4-epossibutirrati alchilici
FR2591600B1 (fr) Derives de la glucosylmoranoline et leur preparation
IT1204813B (it) Gruppo cilindo-stantuffo
KR870004977A (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
KR920002008A (ko) 1,2,4-트리아조로[1,5-c] 피리미딘 및 이의 제조방법
ZA861074B (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
IT1213496B (it) Trimetilsililcarbammati e procedimento per la loro preparazione
NZ214837A (en) 5-substituted 1,6 naphthyridin-2(1h)-ones
KR880700810A (ko) 2'-데옥시-5-트리플루오로메틸우리딘 유도체 및 그의 제조방법
BR8502633A (pt) Metodo de preparacao de 2,3,5,6-tetracloropiridina
ZA86320B (en) 1,6-naphthyridin-2(1h)-ones having cardiotonic activity and preparation
IL89062A (en) Substituted 1,3,9,9a-tetrahydro-2h-imidazo(4,5-b)-quinolin-2-ones and their preparation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee